尊龙凯时人生就是搏·(中国区)官方网站
About Us
About Sino Biopharm
Board of Directors
Senior Management
R&D
R&D Team
Products
Product List
Sustainability
ESG Governance
ESG Management Practices
ESG Reports
Investors
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
News
Press Releases
Contact
CN
EN
Investors
Home
>
Investors
>
Information Disclosure
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
Information Disclosure
VOLUNTARY ANNOUNCEMENT - SIGNING OF AN EXCLUSIVE STRATEGIC COOPERATION AGREEMENT WITH SCIWIND BIOSCIENCES REGARDING PROJECT IL-29
2025.02.27
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF THE FIRST GENERIC “TULOBUTEROL PATCHES”
2025.02.07
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF “LOXOPROFEN SODIUM CATAPLASMS”
2025.02.07
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2025
2025.02.04
NEXT DAY DISCLOSURE RETURN
2025.01.16
NEXT DAY DISCLOSURE RETURN
2025.01.14
NEXT DAY DISCLOSURE RETURN
2025.01.13
NEXT DAY DISCLOSURE RETURN
2025.01.10
首页
上一页
1
2
3
4
5
6
...
51
尾页
下一页